Literature DB >> 33556072

Nationwide seroprevalence of hepatitis A in South Korea from 2009 to 2019.

Deog-Yong Lee1, Su-Jin Chae1, Seung-Rye Cho1, Wooyoung Choi1, Chang-Ki Kim2, Myung-Guk Han1.   

Abstract

Hepatitis A, an acute type of hepatitis caused by the hepatitis A virus, occurs worldwide. Following the 2009 hepatitis A epidemic in South Korea, patient outbreak reports were collectively converted to an "all-patient report" in 2011, and national immunization programs were introduced for children in 2015. In this study, we aimed to analyze the changes and characteristics of hepatitis A antibody titers in South Korea following the epidemic. The results of hepatitis A antibody tests performed at clinical laboratories from 2009 to 2019 were analyzed based on year, age, region, sex, and medical institution. The average 2009-2018 positive anti-hepatitis A virus immunoglobulin G rate was 51.8%, but it increased (56.06%) in 2019. Significantly different antibody-positive rates were observed based on age: <10 years, 54.5%; 20-29 years, 19.5%; ≥50 years, almost 100%. The positive rate of individuals in their teens and 20s gradually increased, whereas that of those in their 30s and 40s gradually decreased. Males had higher antibody-positive rates than females, and samples from higher-level general hospitals exhibited higher antibody rates. The positive anti-hepatitis A virus immunoglobulin M rates gradually decreased after 2009 and were <1% after 2012. However, a high positive rate of 3.69% was observed in 2019 when there was an epidemic. Anti-hepatitis A virus immunoglobulin G-positive rates were similar throughout the year, but the anti-hepatitis A virus immunoglobulin M-positive rates increased from January, peaked in April, and decreased from July, exhibiting distinct seasonality. This is considered to be related to groundwater pollution during the spring drought season. The introduction of the "all-patient report" and national vaccination program for children has had an effective influence on hepatitis A management. However, for hepatitis A prevention, policy considerations for high-risk age groups with low antibody-positive rates will be necessary.

Entities:  

Year:  2021        PMID: 33556072      PMCID: PMC7870085          DOI: 10.1371/journal.pone.0245162

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  12 in total

Review 1.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Genetic variability and molecular evolution of hepatitis A virus.

Authors:  Juan Cristina; Mauro Costa-Mattioli
Journal:  Virus Res       Date:  2007-02-27       Impact factor: 3.303

3.  A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.

Authors:  Donghun Lee; Moran Ki; Anna Lee; Kyoung Ryul Lee; Hee Bong Park; Chang Sub Kim; Bo Young Yoon; Jong Hyun Kim; Young Sok Lee; Sook Hyang Jeong
Journal:  Korean J Hepatol       Date:  2011-03

4.  Genetic characterization of wild-type genotype VII hepatitis A virus.

Authors:  Karen Z Ching; Tatsunori Nakano; Louisa E Chapman; Austin Demby; Betty H Robertson
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

Review 5.  Hepatitis A.

Authors:  Samuel C Matheny; Joe E Kingery
Journal:  Am Fam Physician       Date:  2012-12-01       Impact factor: 3.292

6.  Seasonality of hepatitis: a review update.

Authors:  Auda Fares
Journal:  J Family Med Prim Care       Date:  2015 Jan-Mar

7.  Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009.

Authors:  Kyung-Ah Kim; Anna Lee; Moran Ki; Sook-Hyang Jeong
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

8.  Increase in Hepatitis A Virus Infections - United States, 2013-2018.

Authors:  Monique A Foster; Megan G Hofmeister; Benjamin A Kupronis; Yulin Lin; Guo-Liang Xia; Shaoman Yin; Eyasu Teshale
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-05-10       Impact factor: 17.586

9.  Hepatitis A in Korea from 2011 to 2013: Current Epidemiologic Status and Regional Distribution.

Authors:  Shinje Moon; Jun Hee Han; Geun-Ryang Bae; Enhi Cho; Bongyoung Kim
Journal:  J Korean Med Sci       Date:  2015-12-24       Impact factor: 2.153

10.  Seroprevalence and disease burden of acute hepatitis A in adult population in South Korea.

Authors:  Jin Gu Yoon; Min Joo Choi; Jae Won Yoon; Ji Yun Noh; Joon Young Song; Hee Jin Cheong; Woo Joo Kim
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

View more
  4 in total

1.  An outbreak of hepatitis A associated with salted clams in Busan, Korea.

Authors:  Hyunjin Son; Miyoung Lee; Youngduck Eun; Wonseo Park; Kyounghee Park; Sora Kwon; Seungjin Kim; Changhoon Kim
Journal:  Epidemiol Health       Date:  2021-12-29

2.  Ten-Year Trends of Hepatitis A Seroprevalence in People Living with HIV in Korea.

Authors:  Shinwon Lee; Jeong Eun Lee; Soon Ok Lee; Yong Ki Sim; Sun Hee Lee
Journal:  Infect Chemother       Date:  2022-07-22

Review 3.  Pollution, Inflammation, and Vaccines: A Complex Crosstalk.

Authors:  Laura Franza; Rossella Cianci
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

Review 4.  Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment.

Authors:  Marion Migueres; Sébastien Lhomme; Jacques Izopet
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.